A pharmacokinetic-pharmacodynamic model of d-sotalol Q-Tc prolongation during intravenous administration to healthy subjects.
about
Beta receptor blockade potentiates the antiarrhythmic actions of d-sotalol on reentrant ventricular tachycardia in a canine model of myocardial infarction.ICH E14 Q & A (R1) document: perspectives on the updated recommendations on thorough QT studies.Concentration-QT relationships play a key role in the evaluation of proarrhythmic risk during regulatory review.Understanding the time course of pharmacological effect: a PKPD approach.Adverse effects in women: implications for drug development and regulatory policies.Physiologically based pharmacokinetic models in the prediction of oral drug exposure over the entire pediatric age range-sotalol as a model drug.A GENS-based approach to cardiovascular pharmacology: impact on metabolism, pharmacokinetics and pharmacodynamics
P2860
Q34543962-424D7C79-3B29-418A-9FEB-73863A6D365FQ36729914-79B2B15B-D167-4C36-A03B-4AF04AB56C69Q37038099-12A8A103-7BF4-45F3-9F99-A0DB6F67E4F1Q37832754-FB9DB787-D9FB-411D-AAAB-40C8924D657CQ37960526-4BC6452D-9CBE-49C7-83C5-CD94F393A2BBQ41975490-A9D9D8D0-3B1B-4838-992F-7EF06FAC1B21Q58294605-913F52C2-3735-4E56-94A5-7B69FCB360DD
P2860
A pharmacokinetic-pharmacodynamic model of d-sotalol Q-Tc prolongation during intravenous administration to healthy subjects.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
A pharmacokinetic-pharmacodyna ...... istration to healthy subjects.
@en
A pharmacokinetic-pharmacodyna ...... istration to healthy subjects.
@nl
type
label
A pharmacokinetic-pharmacodyna ...... istration to healthy subjects.
@en
A pharmacokinetic-pharmacodyna ...... istration to healthy subjects.
@nl
prefLabel
A pharmacokinetic-pharmacodyna ...... istration to healthy subjects.
@en
A pharmacokinetic-pharmacodyna ...... istration to healthy subjects.
@nl
P2093
P2860
P1476
A pharmacokinetic-pharmacodyna ...... istration to healthy subjects.
@en
P2093
P2860
P304
P356
10.1002/J.1552-4604.1997.TB05627.X
P577
1997-09-01T00:00:00Z